
OTLK
Outlook Therapeutics Inc
Biotechnology
Outlook Therapeutics Inc (OTLK) Insider Trading
7 transactions reported on SEC Form 4 — executive and director buys and sells.
🔥
Cluster Buy Signal
3+ insiders bought OTLK in the last 30 days — often a sign of internal confidence.
Buys
4
Sells
0
Net value
$2.5M
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| KENYON LAWRENCE A | Chief Financial Officer | Buy | 101,010 | — | 3d ago |
| Sukhtian Ghiath M. | Buy | 2,525,252 | $2.5M | 5d ago | |
| Jahr Robert Charles | Chief Executive Officer | Buy | 151,515 | — | 3d ago |
| Jahr Robert Charles | Chief Executive Officer | Grant | 100,000 | — | 27d ago |
| KENYON LAWRENCE A | Chief Financial Officer | Grant | 210,078 | — | 27d ago |
| Sukhtian Ghiath M. | Buy | 8,539,709 | $0 | May 28, 2026 | |
| Sukhtian Ghiath M. | H | 3,458,571 | — | May 28, 2026 |